P/E at 62.14 vs Industry's 60.05: What the Data Shows for Apollo Hospitals Enterprise Ltd.

1 hour ago
share
Share Via
A price-to-earnings ratio of 62.14 against an industry average of 60.05 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 11 May 2026. While the one-year return of 21.48% comfortably outpaces the Sensex’s decline of 5.28%, the shorter-term performance reveals a more nuanced picture, with recent weeks showing some underperformance. The data presents a compelling valuation-performance tension that merits closer examination.

Valuation Picture: Premium Reflects Confidence Amid Sector Dynamics

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 62.14, slightly above the hospital industry average of 60.05. This premium, while not extreme, suggests investors are willing to pay more for the stock relative to its peers. The sector itself has been characterised by steady growth, with a mix of 12 positive, 3 flat, and 5 negative performers in recent quarterly results, indicating a generally favourable environment for healthcare providers.

Such a valuation premium often implies expectations of superior earnings growth or operational resilience. However, it also raises questions about the sustainability of this premium in light of recent price movements — Apollo Hospitals Enterprise Ltd. trades close to its 52-week high, just 2.17% shy of the peak price of Rs 8,624.2. Previously rated Hold, what is Apollo Hospitals’ current rating? The valuation premium is a key factor in this reassessment.

Performance Across Timeframes: Strong Long-Term Gains, Mixed Recent Momentum

Examining returns over multiple periods reveals a stock that has delivered robust long-term gains. Over three years, Apollo Hospitals Enterprise Ltd. has appreciated by 61.90%, significantly outperforming the Sensex’s 21.71%. The five-year return is even more striking at 161.20%, compared to the Sensex’s 47.38%, while the ten-year performance stands at an impressive 548.65% versus the Sensex’s 189.75%.

However, the short-term picture is more complex. The stock’s one-month return of 4.92% slightly outperforms the Sensex’s 2.43%, and the three-month return of 12.67% is well ahead of the Sensex’s 0.58%. Yet, the one-week performance shows a decline of 0.95% against a 4.49% gain for the Sensex, and the one-day change is a marginal -0.20% versus the Sensex’s -0.01%. This divergence suggests some recent profit-taking or consolidation after a strong rally — is this a temporary pause or a sign of shifting momentum?

Moving Average Configuration: Above Medium and Long-Term Averages, Below 5-Day

The technical setup for Apollo Hospitals Enterprise Ltd. shows the stock trading above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained medium to long-term uptrend. However, it currently sits just below its 5-day moving average, indicating a slight short-term pullback or consolidation phase.

This configuration often points to a stock that is in a recovery or continuation phase after a recent minor correction. The fact that it remains above all major longer-term averages supports the view that the broader trend remains intact. The stock has also recorded two consecutive days of gains, accumulating a 0.61% return in this period, which may hint at renewed buying interest — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?

  • - Building momentum strength
  • - Investor interest growing
  • - Limited time advantage

Join the Momentum →

Sector Context: Hospital Industry Shows Mixed but Generally Positive Results

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has delivered a mixed bag of results recently. Out of 20 companies analysed, 12 reported positive earnings growth, 3 remained flat, and 5 faced declines. This overall positive skew supports the valuation premium enjoyed by Apollo Hospitals Enterprise Ltd., which is among the largest players in the sector with a market capitalisation of Rs 1,21,003.42 crore.

Despite sector headwinds such as rising input costs and regulatory pressures, the company’s ability to maintain growth and outperform the Sensex over multiple timeframes highlights its operational strength. Yet, the recent short-term underperformance relative to the Sensex raises questions about near-term challenges — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Hold, reflecting a reassessment of its valuation and performance metrics. The previous Mojo Score was 78.0, indicating a solid standing within its sector. This reassessment takes into account the company’s premium valuation, strong long-term returns, and recent technical signals.

The rating update invites investors to reanalyse the stock’s position in their portfolios, especially given the valuation-performance tension and the mixed short-term momentum. What is the current rating for Apollo Hospitals Enterprise Ltd. following this reassessment?

Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Conclusion: Data Reflects a Stock Balancing Premium Valuation with Mixed Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector, supported by strong long-term returns and a solid market capitalisation. The moving average configuration suggests the stock remains in an overall uptrend despite short-term consolidation below the 5-day average.

Recent performance divergence, with strong gains over one year and three months but slight weakness over the past week, highlights the importance of timeframe in analysing momentum. The sector’s generally positive results provide a supportive backdrop, yet the rating reassessment from Hold invites a fresh look at the stock’s valuation and technical signals — should investors in Apollo Hospitals hold, buy more, or reconsider?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News